Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...

But multiple federal reports indicated that the law fell short, as insurance companies routinely exploited loopholes to avoid ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

A woman in Bangalore spent years battling fatigue, weight gain, and depression. Doctors attributed her symptoms to aging and stress—until one physician tested her thyroid hormone levels and discovered ...

Climate tech market accelerates rapidly amid net-zero mandates, cloud analytics, dominated by North America's IRA investment, Europe's carbon pricing ...

“Breakthrough,” “miracle,” and “game-changer” are red flags if not backed by details ... Articles with headlines like “Scientists Stun the World” or “This CRISPR Discovery Changes Everything” are ...

CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...